Aztreonam

  • n.氨曲南
AztreonamAztreonam
  1. So we 're going to take her off the aztreonam .

    所以我们打算替她停用氨曲南。

  2. Infections of lung and pleurisy treated with aztreonam in 9 patients

    氨曲南治疗肺部感染和胸膜炎9例

  3. Evaluation of Aztreonam for Treating Respiratory or Urinary Tract Infection in Patients with Chronic Renal Insufficiency

    氨曲南治疗慢性肾功能不全患者肺部及尿路感染疗效

  4. The effect of aztreonam for injection to the treating respiratory pyocyanic infection

    氨曲南治疗呼吸道绿脓杆菌感染52例疗效观察

  5. Evaluation of the antibacterial activities aztreonam in urinary tract , biliary and lower respiratory tract infection

    评价氨曲南对泌尿道、胆道和下呼吸道感染的抗菌活性

  6. The Pharmacology and Clinical Application of Aztreonam

    氨曲南的药理作用及临床应用

  7. We 're hoping the aztreonam will clear it up .

    我们希望用氨曲南可以清除它。

  8. The observed improvements declined during the2 weeks after inhaled aztreonam lysine was stopped .

    在停止吸入氨曲南赖氨酸两周内,观测到的改善状态下降。

  9. Aztreonam was stable to 6 β lactamases , and relative hydrolysis rates were less than 13 % .

    氨曲南对6种酶的稳定性较好,其相对水解率不超过13%;

  10. Acute aplastic anemia and toxic epidermal necrolysis caused by sensitization to aztreonam : the first report

    首例氨曲南导致急性剥脱性皮炎和急性再生障碍性贫血同发

  11. Comparation of The Antibiotic Activity Among Imipenem , Cefoperazone , Sulbactam Aztreonam and Third Generation Cephalosporin

    亚胺培南舒普深氨曲南三代头孢的抗菌活性比较

  12. Objective To evaluate the cost-effectiveness of aztreonam in the treatment of cancer patients with lower respiratory tract infection , promote rational use of the drugs and decrease treatment cost .

    目的评价氨曲南治疗肿瘤患者下呼吸道感染的成本.效果,促进合理用药,降低医疗费用。

  13. Results The drug-resistance rate of imipenem was high to 84.2 % , ceftazidime and aztreonam was 77.7 % and 77.1 % , respectively ;

    结果该菌对碳青酶烯类药物亚胺培南敏感性最高为84.2%,其次为头孢他啶(77.7%)、氨曲南(77.1%);

  14. Aztreonam lysine inhalation was also associated with significantly greater improvements in clinical symptoms , lung function , and sputum density of P.aeruginosa , compared with placebo .

    吸入性氨曲南赖氨酸组较安慰剂组在肺功能、绿脓杆菌痰密度等临床症状上的改善也显著相关。

  15. Twice-daily and thrice-daily aztreonam lysine were similarly effective , and adverse events did not differ significantly between the aztreonam and placebo groups .

    氨曲南赖氨酸每天两次和每天三次的功效相似,并且氨曲南组的不良事件较安慰剂组无显著性差别。

  16. But it was lower resistant to amikacin ( 0 ), aztreonam ( 0.67 % ) and cephalosporins ( 0 ~ 6.67 % ) .

    对阿米卡星、氨曲南的耐药率分别为0和0.67%,对头孢类抗生素的耐药率为0~6.67%。

  17. Comparative Induction of Imipenem , Cefepime , Ceftriaxone and Aztreonam to Enterobacter Cloacae AmpC β - lactamase ; Regional Bureau for South and South-East Asia

    亚胺培南、头孢吡肟、头孢曲松和氨曲南对阴沟肠杆菌AmpC酶的诱导性研究南亚和东南亚区域局

  18. The resistance rates of ESBLs-producing isolates against penicillins , aztreonam and the third generation cephalosporins were about 56.2 % - 100 % , and almost multi-resistant .

    产ESBLs菌对青霉素类、氨曲南及头孢菌素类抗生素耐药率为56.2%~100%,具有多重耐药特点。

  19. There were 16 strains out of 36 of MBL bacteria with complete resistance to Imipenem / cilastatin sodium , but with higher susceptibility to aztreonam than those non-MBL producing strains .

    36株菌中16株产MBL菌对亚胺培南西司他丁钠盐完全耐药,对氨曲南的敏感性高于非产MBL株。

  20. 55 % E. coli strains were highly resistant to Ciprofloxacin ( MIC ≥ 32 μ g / ml ) To induce β lactamase producing strains , cross resistance existed among the third generation cephalosporins and Aztreonam .

    55%的大肠埃希菌高耐环丙沙星(MIC≥32μg/ml)。三代头孢菌素及氨曲南对产诱导酶菌株呈交叉耐药;

  21. The resistance rate of Piperacillin / tazobactam , Ceftazidime , Amikacin , Ciprofloxacin , Imipenem , Aztreonam , Piperacillin , ceftriaxone and Gentamicin were 15.1 % - 45.8 % .

    哌拉西林/三唑巴坦、头孢他啶、阿米卡星、环丙沙星、亚胺培南、安曲南、哌拉西林、头孢曲松和庆大霉素等抗生素耐药率较低,为15.1%~45.8%。

  22. The antibacterial activity of aztreonam against 81 multiresistant Gram-negative bacilli was quite good , the MICs of only 13 strains were > 8 μ g / ml and 84.0 % of strains were susceptible to aztreonam .

    同时还测定了Aztreonam对81株多重耐药菌的抗菌作用,其中只有13株菌的MIC大于8μg/ml,总抑菌率为84.0%。本研究为Aztreonam的临床应用提供了参考。

  23. METHODS : Fifty-two patients with respiratory pyocyanic infections ( M33 . F19 ; age 61.2 ± 4.5 a ), received aztreonam for injection 4  ̄ 8 g · d - 1 iv for 12.5 ± 2.5 d.

    方法:呼吸道绿脓杆菌感染52例(男33例,女19例,年龄61.2±4.5岁),以氨曲南4~8g·d-1,静脉推注,疗程12.5±2.5d。

  24. Baumannii strains . RESULTS The antibiotic resistance test indicated that A. baumannii was most sensitive to imipenem , with 11.1 % of resistance rate , but highly resistant to penicillins , cephalosporins and helices β - lactam antibiotics , especially piperacillin and aztreonam .

    结果106株鲍氏不动杆菌对亚胺培南耐药率最低11.1%,对青霉素类、头孢菌素类和单环β-内酰胺类抗生素耐药率均较高,特别是氨曲南和哌拉西林;